• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

β-环糊精-诺氟沙星包合物的研究。第1部分。制备、理化及微生物学特性

Investigation of β-cyclodextrin-norfloxacin inclusion complexes. Part 1. Preparation, physicochemical and microbiological characterization.

作者信息

Mendes Cassiana, Wiemes Bárbara Paula, Buttchevitz Aline, Christ Ana Paula, Ribas Karla Giacomelli, Adams Andréa Inês Horn, Silva Marcos Antônio Segatto, Oliveira Paulo Renato

机构信息

Department of Pharmaceutical Sciences, Health Science Centre, Federal University of Santa Catarina, Quality Control Laboratory, J/K 207, 88040-900, Florianópolis-SC, Brazil.

出版信息

Expert Rev Anti Infect Ther. 2015 Jan;13(1):119-29. doi: 10.1586/14787210.2015.982091.

DOI:10.1586/14787210.2015.982091
PMID:25488142
Abstract

INTRODUCTION

Drugs classified as class IV by the Biopharmaceutical Classification System present significant problems in relation to effective oral administration. In the case of antibiotics, the subsequently high doses required can enhance the emergence of microorganism resistance and lead to a low rate of patient treatment adherence.

OBJECTIVE

In an attempt to improve physicochemical properties and microbiological activity of norfloxacin, the aim of this study was to investigate different methods (coevaporation, kneading followed by freeze-drying or spray-drying) to obtain complexes of norfloxacin and different cyclodextrins.

METHODS

Guest-host interactions were investigated through a complete physical-chemical characterization and the dissolution profile and microbiological activity were determined.

RESULTS

The formation of a complex of norfloxacin and β-cyclodextrin (1:1), obtained by kneading followed by freeze drying, led to increased drug solubility, which could maximize the oral drug absorption.

CONCLUSION

Moreover, the microbiological activity was enhanced by around 23.3%, demonstrating that the complex formed could represent an efficient drug delivery system.

摘要

引言

生物药剂学分类系统中归类为IV类的药物在有效口服给药方面存在重大问题。就抗生素而言,随后所需的高剂量会增加微生物耐药性的出现,并导致患者治疗依从率较低。

目的

为了改善诺氟沙星的物理化学性质和微生物活性,本研究的目的是研究不同方法(共蒸发、捏合后冷冻干燥或喷雾干燥)以获得诺氟沙星与不同环糊精的复合物。

方法

通过全面的物理化学表征研究客体-主体相互作用,并测定溶出曲线和微生物活性。

结果

通过捏合后冷冻干燥获得的诺氟沙星与β-环糊精(1:1)复合物的形成导致药物溶解度增加,这可以使口服药物吸收最大化。

结论

此外,微生物活性提高了约23.3%,表明形成的复合物可以代表一种有效的药物递送系统。

相似文献

1
Investigation of β-cyclodextrin-norfloxacin inclusion complexes. Part 1. Preparation, physicochemical and microbiological characterization.β-环糊精-诺氟沙星包合物的研究。第1部分。制备、理化及微生物学特性
Expert Rev Anti Infect Ther. 2015 Jan;13(1):119-29. doi: 10.1586/14787210.2015.982091.
2
Investigation of β-cyclodextrin-norfloxacin inclusion complexes. Part 2. Inclusion mode and stability studies.β-环糊精-诺氟沙星包合物的研究。第2部分。包合模式与稳定性研究。
Expert Rev Anti Infect Ther. 2015 Jan;13(1):131-40. doi: 10.1586/14787210.2015.982092.
3
Influence of β-cyclodextrin on the Properties of Norfloxacin Form A.β-环糊精对诺氟沙星A晶型性质的影响
AAPS PharmSciTech. 2015 Jun;16(3):683-91. doi: 10.1208/s12249-014-0259-8. Epub 2014 Dec 16.
4
Inclusion complexes of hydrochlorothiazide and β-cyclodextrin: Physicochemical characteristics, in vitro and in vivo studies.氢氯噻嗪与β-环糊精的包合物:物理化学特性、体外和体内研究
Eur J Pharm Sci. 2016 Feb 15;83:71-8. doi: 10.1016/j.ejps.2015.12.015. Epub 2015 Dec 11.
5
Improving the Stability and the Pharmaceutical Properties of Norfloxacin Form C Through Binary Complexes with β-Cyclodextrin.通过与β-环糊精形成二元复合物来提高诺氟沙星 C 型的稳定性和药物性能。
AAPS PharmSciTech. 2018 Jul;19(5):2255-2263. doi: 10.1208/s12249-018-1033-0. Epub 2018 May 10.
6
Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.他达拉非与天然及化学修饰的β-环糊精的包合物。I:制备及体外评价
Eur J Pharm Biopharm. 2008 Nov;70(3):819-27. doi: 10.1016/j.ejpb.2008.06.024. Epub 2008 Jul 4.
7
β-cyclodextrin complexation as an approach to enhance the biopharmaceutical properties of Norfloxacin B Hydrate.β-环糊精包合作为提高诺氟沙星 B 水合物生物制药特性的方法。
Carbohydr Res. 2019 Nov 1;485:107818. doi: 10.1016/j.carres.2019.107818. Epub 2019 Sep 13.
8
Influence of the preparation method on the physicochemical properties of indomethacin and methyl-β-cyclodextrin complexes.制备方法对吲哚美辛与甲基-β-环糊精复合物理化性质的影响。
Int J Pharm. 2015 Feb 20;479(2):381-90. doi: 10.1016/j.ijpharm.2015.01.010. Epub 2015 Jan 8.
9
Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin.奥美拉唑与天然及化学修饰β-环糊精包合物的固态表征及溶出曲线
Eur J Pharm Biopharm. 2007 Sep;67(2):531-9. doi: 10.1016/j.ejpb.2007.03.005. Epub 2007 Mar 13.
10
Preparation & characterization of solid inclusion complex of cefpodoxime proxetil with beta-cyclodextrin.头孢泊肟酯与β-环糊精的固体包合物的制备与表征
Curr Drug Deliv. 2008 Jan;5(1):1-6. doi: 10.2174/156720108783330998.

引用本文的文献

1
Synergistic Antibacterial Action of Norfloxacin-Encapsulated G4 Hydrogels: The Role of Boronic Acid and Cyclodextrin.载诺氟沙星的G4水凝胶的协同抗菌作用:硼酸和环糊精的作用
Gels. 2025 Jan 4;11(1):35. doi: 10.3390/gels11010035.
2
Cyclodextrin Inclusion Complexes with Antibiotics and Antibacterial Agents as Drug-Delivery Systems-A Pharmaceutical Perspective.环糊精与抗生素及抗菌剂形成的包合物作为药物递送系统——药学视角
Pharmaceutics. 2022 Jun 30;14(7):1389. doi: 10.3390/pharmaceutics14071389.
3
Antimicrobial Activities of Highly Bioavailable Organic Salts and Ionic Liquids from Fluoroquinolones.
氟喹诺酮类高生物利用度有机盐和离子液体的抗菌活性
Pharmaceutics. 2020 Jul 23;12(8):694. doi: 10.3390/pharmaceutics12080694.
4
Computational investigation on the host-guest inclusion process of norfloxacin into β-cyclodextrin.诺氟沙星与β-环糊精主客体包合过程的计算研究
J Mol Model. 2016 Sep;22(9):220. doi: 10.1007/s00894-016-3098-6. Epub 2016 Aug 24.
5
Characterization of pioglitazone cyclodextrin complexes: Molecular modeling to in vivo evaluation.吡格列酮环糊精复合物的表征:从分子模拟到体内评估
J Pharm Bioallied Sci. 2016 Apr-Jun;8(2):161-9. doi: 10.4103/0975-7406.171680.